Anticorps Polyclonal de lapin anti-ASNA1

• Phare
• Validé par KD/KO

ASNA1 Polyclonal Antibody for WB, IP, IF, IHC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, IF/ICC, IP, ELISA

Conjugaison

Non conjugué

Publications

6

N° de cat : 15450-1-AP

Synonymes

ARSA, ARSA I, ARSA1, ASNA1, ATPase ASNA1, hARSA I, hASNA I, TRC40

---

Galerie de données de validation

• 

  WB analysis of human brain using 15450-1-AP

  human brain tissue were subjected to SDS PAGE followed by western blot with 15450-1-AP (ASNA1 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of human heart using 15450-1-AP

  human heart tissue were subjected to SDS PAGE followed by western blot with 15450-1-AP (ASNA1 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HeLa using 15450-1-AP

  HeLa cells were subjected to SDS PAGE followed by western blot with 15450-1-AP (ASNA1 Antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of mouse brain using 15450-1-AP

  mouse brain tissue were subjected to SDS PAGE followed by western blot with 15450-1-AP (ASNA1 Antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  IP experiment of mouse brain using 15450-1-AP

  IP result of anti-ASNA1 (IP:15450-1-AP, 4ug; Detection:15450-1-AP 1:1000) with mouse brain tissue lysate 4000ug.

• 

  IHC staining of human lung cancer using 15450-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung cancer using 15450-1-AP (ASNA1 antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human lung cancer using 15450-1-AP

  Immunohistochemical analysis of paraffin-embedded human lung cancer using 15450-1-AP (ASNA1 antibody) at dilution of 1:50 (under 40x lens).

• 

  IF Staining of HepG2 using 15450-1-AP

  Immunofluorescent analysis of HepG2 cells, using ASNA1 antibody 15450-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).

---

Applications testées

• Résultats positifs en WB: tissu cérébral humain, cellules HeLa, tissu cardiaque humain, tissu cérébral de souris
• Résultats positifs en IP: tissu cérébral de souris
• Résultats positifs en IHC: tissu de cancer du poumon humain; il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
• Résultats positifs en IF/ICC: cellules HepG2

Dilution recommandée

• Western Blot (WB): WB : 1:500-1:1000
• Immunoprécipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
• Immunohistochimie (IHC): IHC : 1:20-1:200
• Immunofluorescence (IF)/ICC: IF/ICC : 1:10-1:100

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• KD/KO: See 3 publications below
• WB: See 6 publications below

Informations sur le produit

15450-1-AP cible ASNA1 dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

• Réactivité: Humain, rat, souris
• Réactivité citée: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: ASNA1 Protéine recombinante Ag7713
• Nom complet: arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)
• Masse moléculaire calculée: 38.7 kDa
• Poids moléculaire observé: 37-41 kDa
• Numéro d’acquisition GenBank: BC002651
• Symbole du gène: ASNA1
• Identification du gène (NCBI): 439
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

ASNA1 (also known as TRC40) is a highly conserved ATPase involved in efflux of arsenite and antimonite. Reduced ASNA1 expression is associated with significant inhibition of cell growth, increased apoptosis and increased sensitivity to DDP and arsenite.Thus ASNA1 is proposed to be a target to overcome resistance to cancer chemotherapy. In addition, ASNA1 has been identified as an ER targeting factor for tail-anchored proteins in the posttranslational membrane insertion pathway.

Publications

Species	Application	Title
human	WB	Mol Cell; Molecular machinery for insertion of tail-anchored membrane proteins into the endoplasmic reticulum membrane in mammalian cells.; Authors - Yasunori Yamamoto
human	WB	J Cell Sci; Emery-Dreifuss muscular dystrophy mutations impair TRC40-mediated targeting of emerin to the inner nuclear membrane.; Authors - Janine Pfaff ; KD Validated
human	WB	J Cell Sci; An alternative membrane topology permits lipid droplet localization of peroxisomal fatty acyl-CoA reductase 1.; Authors - Tarik Exner ; KD Validated
human	WB	J Cell Sci; A trap mutant reveals the physiological client spectrum of TRC40.; Authors - Javier Coy-Vergara ; KD Validated
human	WB	J Biol Chem; ER entry pathway and glycosylation of GPI-anchored proteins are determined by N-terminal signal sequence and C-terminal GPI-attachment sequence; Authors - Tetsuya Hirata
human	WB	FEBS Lett; Human SND2 mediates ER targeting of GPI-anchored proteins with low hydrophobic GPI attachment signals.; Authors - Jing Yang